静脉注射注射液市场规模、份额、成长分析、按产品、按营养素、按地区 - 产业预测，2024-2031 年

2022年全球静脉注射输液市场规模为119.9亿美元，从2023年的129.5亿美元成长到2031年的239.6亿美元，在预测期内（2024-2031年）预计复合年增长率为8.0。

全球静脉注射输液市场呈现稳定成长，主要得益于慢性病增加、家庭医疗服务需求增加、老年人口快速成长。这些无菌液体在病患照护中发挥重要作用，包括水合作用、营养以及药物和电解质的管理。技术进步，特别是输液设备的技术进步，以及产业向永续製造和包装方法的转变，正在进一步推动市场扩张。然而，竞争格局并非没有挑战，严格的监管条件、高昂的製造成本以及新兴企业和成熟企业之间的竞争加剧阻碍了成长。儘管存在这些障碍，新的机会正在出现，特别是随着对静脉注射的日益关注以及对个人化医疗策略的需求不断增长。随着市场的发展，相关人员需要应对这些复杂的情况，同时利用技术创新和不断变化的消费者偏好，以增强其在 2024-203187静脉注射液体领域的地位。

目录

介绍

• 研究目的
• 调查范围
• 定义

调查方法

• 资讯采购
• 二手资料和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 技术进步
• 监管环境
• 专利分析
• 价值链分析
• PESTEL分析
• 总体经济指标
• 供应链分析
• 价格分析

静脉静脉注射市场规模：依产品分类

• 全肠外营养
• 週边肠外营养

静脉注射液市场规模：依营养素分类

• 碳水化合物
• 维生素和矿物质
• 单剂量胺基酸
• 肠外脂肪乳剂
• 其他的

静脉注射注射市场规模：按地区划分

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争资讯

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2023）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• Akshar Pharma
• Fresenius Kabi AG
• MEDEVAC LIFESCIENCES PVT LTD
• Pfizer, Inc.
• LXIR MEDILABS PVT. LTD
• Otsuka Pharmaceutical Co., Ltd.
• Baxter
• B. Braun
• Melsungen AG
• Aishwarya Healthcare
• Vifor Pharma Management Ltd.
• JW Life Science
• Amanta Health Care
• ICU Medical, Inc.
• Grifols SA
• AptarGroup, Inc.
• Sagent Pharmaceuticals, Inc.
• Amgen Inc.
• Novartis AG

结论和建议

Global Intravenous Solutions Market size was valued at USD 11.99 Billion in 2022 and is poised to grow from USD 12.95 Billion in 2023 to USD 23.96 Billion by 2031, growing at a CAGR of 8.0% in the forecast period (2024-2031).

The global intravenous (IV) solutions market is showing robust growth, primarily driven by an increase in chronic disease prevalence, heightened demand for home healthcare services, and a burgeoning elderly population. These sterile liquids serve crucial roles in patient care-providing hydration, nutritional support, and the administration of medications and electrolytes. Technological advancements, particularly in infusion devices, along with an industry shift towards sustainable manufacturing and packaging methods, are further propelling market expansion. However, the landscape is not without challenges; stringent regulatory requirements, high manufacturing expenses, and intensifying competition between emerging and established firms present obstacles to growth. Despite these hurdles, new opportunities are emerging, especially with a heightened focus on nutritional IV solutions and the rising demand for personalized medicine strategies. As the market evolves, stakeholders must navigate these complexities while capitalizing on innovation and shifting consumer preferences to enhance their positioning in the intravenous solutions sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intravenous Solutions market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intravenous Solutions Market Segmental Analysis

Global Intravenous Solutions Market is segmented by Product, Nutrients, and region. Based on Product, the market is segmented into Total Parenteral Nutrition, Peripheral Parenteral Nutrition. Based on Nutrients, the market is segmented into Carbohydrates, Vitamins & Minerals, Single-dose Amino Acids, Parenteral Lipid Emulsion, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Intravenous Solutions Market

The Global Intravenous Solutions market is experiencing significant growth due to the remarkable rise in home healthcare services. An increasing number of patients are opting for treatments in the comfort of their own homes, particularly those managing chronic conditions, which is driving the demand for home-based IV and infusion therapies. This shift not only enhances patient comfort but also improves treatment adherence, prompting healthcare professionals to expand their offerings of intravenous solutions specifically for home use. As a result, the market is witnessing a surge in demand for adaptable and convenient intravenous therapies that cater to the evolving preferences of patients.

Restraints in the Global Intravenous Solutions Market

The Global Intravenous Solutions market faces significant restraints primarily due to safety concerns and the potential for contamination during the administration or production of IV technologies. These issues can lead to increased regulatory scrutiny and challenges, ultimately hindering the widespread adoption of these solutions and stunting market growth. Furthermore, patients might experience side effects from specific intravenous therapies, which could cause hesitation among healthcare professionals in utilizing such products. This apprehension not only affects the confidence of providers but also contributes to a reluctance in recommending IV treatments, further impacting the overall trajectory of the market.

Market Trends of the Global Intravenous Solutions Market

The Global Intravenous Solutions market is witnessing a significant trend towards home infusion therapy, driven by advancements in portable infusion technologies that enhance patient comfort and outcomes. This shift not only reduces the reliance on hospital admissions but also allows individuals with chronic diseases to receive their treatments in a familiar environment. The integration of telehealth services further supports this trend by enabling healthcare providers to remotely monitor patients, ensuring timely interventions and personalized care. As a result, the market is poised for growth, with increasing demand for innovative intravenous solutions that cater to the evolving needs of patients and healthcare systems.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Technological Advancement
• Regulatory Landscape
• Patent Analysis
• Value Chain Analysis
• PESTEL Analysis
• Macro-Economic Indicators
• Supply Chain Analysis
• Pricing Analysis

Global Intravenous Solutions Market Size by Product & CAGR (2024-2031)

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

Global Intravenous Solutions Market Size by Nutrients & CAGR (2024-2031)

• Carbohydrates
• Vitamins & Minerals
• Single-dose Amino Acids
• Parenteral Lipid Emulsion
• Others

Global Intravenous Solutions Market Size & CAGR (2024-2031)

• North America, (Product, Nutrients)
  • US
  • Canada
• Europe, (Product, Nutrients)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (Product, Nutrients)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (Product, Nutrients)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (Product, Nutrients)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Akshar Pharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDEVAC LIFESCIENCES PVT LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LXIR MEDILABS PVT. LTD
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Otsuka Pharmaceutical Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melsungen AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aishwarya Healthcare
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vifor Pharma Management Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JW Life Science
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amanta Health Care
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ICU Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AptarGroup, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sagent Pharmaceuticals, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amgen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation